Filing Details
RELMADA THERAPEUTICS, INC. (NASDAQ:RLMD) filed a Form 8-K with the Securities and Exchange Commission on July 28, 2026, disclosing a material event.
8k filedNASDAQ:RLMD
RELMADA THERAPEUTICS, INC. (RLMD) Reports Material Event to SEC
Filing Details RELMADA THERAPEUTICS, INC. (NASDAQ:RLMD) filed a Form 8-K with the Securities and Exchange Commission on July 28, 2026, disclosing a material event. Market Context…
Market Context
RELMADA THERAPEUTICS, INC.'s stock currently trades at $5.23 with a market capitalization of $309.5M. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for RELMADA THERAPEUTICS, INC.'s stock.
All SEC filings for RELMADA THERAPEUTICS, INC. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View RLMD Stock Page
Frequently Asked Questions
Where can I read RLMD's SEC filings?
Browse all filings on our RLMD SEC filings page.
What types of SEC filings does RELMADA THERAPEUTICS, INC. file?
Public companies like RELMADA THERAPEUTICS, INC. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.